Clinical Trials Browser

Phase 2 × Advanced Cancer × Ipilimumab × Clear all

NCT02996110 2022-12-19

FRACTION-RCC

Phase 2 Completed

182 enrolled 23 charts

Advanced Cancer

NCT02750514 2021-03-22

FRACTION-Lung

Phase 2 Terminated

295 enrolled 21 charts

Advanced Cancer